Epithelial overexpression of interleukin-32α in inflammatory bowel disease

Clinical and Experimental Immunology

Volumn 149, Issue 3, 2007, Pages 480-486

  Shioya, M ^a   Nishida, A ^a   Yagi, Y ^a   Ogawa, A ^a   Tsujikawa, T ^a   Kim Mitsuyama, S ^b   Takayanagi, A ^c   Shimizu, N ^c   Fujiyama, Y ^a   Andoh, A ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

^c KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cytokine; IBD; NOD2

Indexed keywords

CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 32ALPHA; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CROHN DISEASE; ENDOSCOPY; ENTERITIS; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOSTIMULATION; INTESTINE EPITHELIUM; INTESTINE EPITHELIUM CELL; ISCHEMIC COLITIS; NORTHERN BLOTTING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; TISSUE SECTION; ULCERATIVE COLITIS;

ADULT; COLON; CYTOKINES; FEMALE; GENE EXPRESSION; HUMANS; IMMUNITY, MUCOSAL; IMMUNOENZYME TECHNIQUES; INFLAMMATORY BOWEL DISEASES; INTERLEUKINS; INTESTINAL MUCOSA; MALE; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 34547887644     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2007.03439.x     Document Type: Article

References (36)

1. Podolsky DK. Inflammatory bowel disease. N Engl J Med 2002 347 : 417 29.
2. Hibi T, Ogata H. Novel pathophysiological concepts of inflammatory bowel disease. J Gastroenterol 2006 41 : 10 6.
3. Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 2004 126 : 1504 17.
4. Kim SH, Han SY, Azam T, Yoon DY, Dinarello CA. Interleukin-32: a cytokine and inducer of TNFalpha. Immunity 2005 22 : 131 42.
5. Netea MG, Azam T, Ferwerda G et al. IL-32 synergizes with nucleotide oligomerization domain (NOD) 1 and NOD2 ligands for IL-1beta and IL-6 production through a caspase 1-dependent mechanism. Proc Natl Acad Sci USA 2005 102 : 16309 14.
6. Dinarello CA, Kim SH. IL-32, a novel cytokine with a possible role in disease. Ann Rheum Dis 2006 65 (Suppl. 3 iii61 4.
7. Chen Q, Carroll HP, Gadina M. The newest interleukins: recent additions to the ever-growing cytokine family. Vitam Horm 2006 74 : 207 28.
8. Peyrin-Biroulet L, Vignal C, Dessein R, Simonet M, Desreumaux P, Chamaillard M. NODs in defence: from vulnerable antimicrobial peptides to chronic inflammation. Trends Microbiol 2006 14 : 432 8.
9. Hugot JP, Chamaillard M, Zouali H et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001 411 : 599 603.
10. Hugot JP. CARD15/NOD2 mutations in Crohn's disease. Ann NY Acad Sci 2006 1072 : 9 18.
11. Netea MG, Ferwerda G, de Jong DJ et al. Nucleotide-binding oligomerization domain-2 modulates specific TLR pathways for the induction of cytokine release. J Immunol 2005 174 : 6518 23.
12. Netea MG, Kullberg BJ, de Jong DJ et al. NOD2 mediates anti-inflammatory signals induced by TLR2 ligands: implications for Crohn's disease. Eur J Immunol 2004 34 : 2052 9.
13. Maeda S, Hsu LC, Liu H et al. Nod2 mutation in Crohn's disease potentiates NF-kappaB activity and IL-1beta processing. Science 2005 307 : 734 8.
14. Cagnard N, Letourneur F, Essabbani A et al. Interleukin-32, CCL2, PF4F1 and GFD10 are the only cytokine/chemokine genes differentially expressed by in vitro cultured rheumatoid and osteoarthritis fibroblast-like synoviocytes. Eur Cytokine Netw 2005 16 : 289 92.
15. Joosten LA, Netea MG, Kim SH et al. IL-32, a proinflammatory cytokine in rheumatoid arthritis. Proc Natl Acad Sci USA 2006 103 : 3298 303.
16. Shoda H, Fujio K, Yamaguchi Y et al. Interactions between IL-32 and tumor necrosis factor alpha contribute to the exacerbation of immune-inflammatory diseases. Arthritis Res Ther 2006 8 : R166.
17. Kundu M, Basu J. IL-32: an emerging player in the immune response network against tuberculosis? PLoS Med 2006 3 : e274.
18. Netea MG, Azam T, Lewis EC et al. Mycobacterium tuberculosis induces interleukin-32 production through a caspase-1/IL-18/interferon-gamma-dependent mechanism. PLoS Med 2006 3 : e277.
19. Zweibaum A, Pinto M, Chevalier G et al. Enterocytic differentiation of a subpopulation of the human colon tumor cell line HT-29 selected for growth in sugar-free medium and its inhibition by glucose. J Cell Physiol 1985 122 : 21 9.
20. Rousset M, Laburthe M, Pinto M et al. Enterocytic differentiation and glucose utilization in the human colon tumor cell line Caco-2: modulation by forskolin. J Cell Physiol 1985 123 : 377 85.
21. Eckmann L, Kagnoff MF, Fierer J. Epithelial cells secrete the chemokine interleukin-8 in response to bacterial entry. Infect Immun 1993 61 : 4569 74.
22. Eckmann L, Jung HC, Schurer-Maly C, Panja A, Morzycka-Wroblewska E, Kagnoff MF. Differential cytokine expression by human intestinal epithelial cell lines: regulated expression of interleukin 8. Gastroenterology 1993 105 : 1689 97.
23. Rachmilewitz D. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. BMJ 1989 298 : 82 6.
24. Best WR, Becktel JM, Singleton JW, Kern F Jr. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterol 1976 70 : 439 44.
25. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987 162 : 156 9.
26. Andoh A, Fujiyama Y, Sumiyoshi K, Sakumoto H, Bamba T. Interleukin 4 acts as an inducer of decay-accelerating factor gene expression in human intestinal epithelial cells. Gastroenterology 1996 111 : 911 8.
27. Andoh A, Takaya H, Saotome T et al. Cytokine regulation of chemokine (IL-8, MCP-1, and RANTES) gene expression in human pancreatic periacinar myofibroblasts. Gastroenterology 2000 119 : 211 19.
28. Shimada M, Andoh A, Hata K et al. IL-6 secretion by human pancreatic periacinar myofibroblasts in response to inflammatory mediators. J Immunol 2002 168 : 861 8.
29. Obara H, Takayanagi A, Hirahashi J et al. Overexpression of truncated IkappaBalpha induces TNF-alpha-dependent apoptosis in human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2000 20 : 2198 204.
30. Yasumoto H, Kim S, Zhan Y et al. Dominant negative c-jun gene transfer inhibits vascular smooth muscle cell proliferation and neointimal hyperplasia in rats. Gene Ther 2001 8 : 1682 9.
31. Sartor RB. Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol 2006 3 : 390 407.
32. Michelsen KS, Arditi M. Toll-like receptors and innate immunity in gut homeostasis and pathology. Curr Opin Hematol 2007 14 : 48 54.
33. Berrebi D, Maudinas R, Hugot JP et al. Card15 gene overexpression in mononuclear and epithelial cells of the inflamed Crohn's disease colon. Gut 2003 52 : 840 6.
34. Rosenstiel P, Fantini M, Brautigam K et al. TNF-alpha and IFN-gamma regulate the expression of the NOD2 (CARD15) gene in human intestinal epithelial cells. Gastroenterology 2003 124 : 1001 9.
35. Goda C, Kanaji T, Kanaji S et al. Involvement of IL-32 in activation-induced cell death in T cells. Int Immunol 2006 18 : 233 40.
36. Kim JM, Eckmann L, Savidge TC, Lowe DC, Witthoft T, Kagnoff MF. Apoptosis of human intestinal epithelial cells after bacterial invasion. J Clin Invest 1998 102 : 1815 23.